Regulatory functions of B cells in allergic diseases

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 11, 2014, Pages 1454-1463

  Braza, F ^a,b,c   Chesne, J ^a,b,c   Castagnet, S ^d   Magnan, A ^a,b,c   Brouard, S ^b,c  

^a L INSTITUT DU THORAX   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

allergy; B cells; IL 10; immunotherapy; regulatory B cells

Indexed keywords

ALLERGEN; FAS LIGAND; GRANZYME B; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL EXPANSION; CYTOKINE PRODUCTION; HUMAN; HYGIENE HYPOTHESIS; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MICROORGANISM; NONHUMAN; PHENOTYPE; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; BIOSYNTHESIS; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM;

ANIMALS; B-LYMPHOCYTES, REGULATORY; HUMANS; HYPERSENSITIVITY; IMMUNOMODULATION; INFLAMMATION; INTERLEUKIN-10;

EID: 84907889488     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12490     Document Type: Review

References (93)

1. Soyer OU, Akdis M, Ring J, Behrendt H, Crameri R, Lauener R, et al. Mechanisms of peripheral tolerance to allergens. Allergy 2013; 68: 161-170.
2. Larché M,. Regulatory T cells in allergy and asthma. Chest 2007; 132: 1007-1014.
3. Taylor A, Verhagen J, Akdis CA, Akdis M,. T regulatory cells in allergy and health: a question of allergen specificity and balance. Int Arch Allergy Immunol 2004; 135: 73-82.
4. Mauri C, Bosma A,. Immune regulatory function of B cells. Annu Rev Immunol 2012; 30: 221-241.
5. Dass S, Vital EM, Emery P,. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 2007; 56: 2715-2718.
6. Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF,. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 2007; 13: 1365-1368.
7. Hartung HP, Kieseier BC,. Atacicept: targeting B cells in multiple sclerosis. Ther Adv Neurol Disord 2010; 3: 205-216.
8. Lee SJ, Noh G, Lee JH,. In vitro induction of allergen-specific interleukin-10-producing regulatory B cell responses by interferon-gamma in non-immunoglobulin E-mediated milk allergy. Allergy Asthma Immunol Res 2013; 5: 48-54.
9. Noh J, Noh G, Lee SJ, Lee JH, Kim A, Kim HS, et al. Tolerogenic effects of interferon-gamma with induction of allergen-specific interleukin-10-producing regulatory B cell (Br 1) changes in non-IgE-mediated food allergy. Cell Immunol 2012; 273: 140-149.
10. van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Sollner S, Akdis DG, et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 2013; 131: 1204-1212.
11. Katz SI, Parker D, Turk JL,. B-cell suppression of delayed hypersensitivity reactions. Nature 1974; 251: 550-551.
12. Shimamura T, Habu S, Hashimoto K, Sasaki S,. Feedback suppression of the immune response in vivo. III. Lyt-1+ B cells are suppressor-inducer cells. Cell Immunol 1984; 83: 221-224.
13. Matsushita T, Horikawa M, Iwata Y, Tedder TF,. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 2010; 185: 2240-2252.
14. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr,. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996; 184: 2271-2278.
15. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF,. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28: 639-650.
16. Yanaba K, Kamata M, Ishiura N, Shibata S, Asano Y, Tada Y, et al. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. J Leukoc Biol 2013; 94: 563-573.
17. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM,. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3: 944-950.
18. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK,. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16: 219-230.
19. Carter NA, Vasconcellos R, Rosser EC, Tulone C, Munoz-Suano A, Kamanaka M, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 2011; 186: 5569-5579.
20. Lampropoulou V, Calderon-Gomez E, Roch T, Neves P, Shen P, Stervbo U, et al. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol Rev 2010; 233: 146-161.
21. Lampropoulou V, Hoehlig K, Roch T, Neves P, Calderon Gomez E, Sweenie CH, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008; 180: 4763-4773.
22. Dalwadi H, Wei B, Schrage M, Spicher K, Su TT, Birnbaumer L, et al. B cell developmental requirement for the G alpha i2 gene. J Immunol 2003; 170: 1707-1715.
23. Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, Isenberg DA, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009; 182: 3492-3502.
24. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007; 178: 7868-7878.
25. Madan R, Demircik F, Surianarayanan S, Allen JL, Divanovic S, Trompette A, et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol 2009; 183: 2312-2320.
26. Maseda D, Smith SH, DiLillo DJ, Bryant JM, Candando KM, Weaver CT, et al. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol 2012; 188: 1036-1048.
27. Scapini P, Lamagna C, Hu Y, Lee K, Tang Q, DeFranco AL, et al. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc Natl Acad Sci USA 2011; 108: 823-832.
28. Neves P, Lampropoulou V, Calderon-Gomez E, Roch T, Stervbo U, Shen P, et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 2010; 33: 777-790.
29. Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014; 507: 366-370.
30. Nishimura S, Manabe I, Takaki S, Nagasaki M, Otsu M, Yamashita H, et al. Adipose Natural Regulatory B Cells Negatively Control Adipose Tissue Inflammation. Cell Metab 2013; 18: 759-766.
31. Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007; 178: 6092-6099.
32. Correale J, Farez M, Razzitte G,. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 2008; 64: 187-199.
33. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010; 32: 129-140.
34. Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, et al. CD19+ CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 2013; 5: 173ra123.
35. Li X, Zhong H, Bao W, Boulad N, Evangelista J, Haider MA, et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood 2012; 120: 3318-3325.
36. Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 2010; 40: 2686-2691.
37. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011; 117: 530-541.
38. Lemoine S, Morva A, Youinou P, Jamin C,. Human T cells induce their own regulation through activation of B cells. J Autoimmun 2011; 36: 228-238.
39. DiLillo DJ, Weinberg JB, Yoshizaki A, Horikawa M, Bryant JM, Iwata Y, et al. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia 2013; 27: 170-182.
40. Gary-Gouy H, Harriague J, Bismuth G, Platzer C, Schmitt C, Dalloul AH,. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 2002; 100: 4537-4543.
41. Cherukuri A, Rothstein DM, Clark B, Carter CR, Davison A, Hernandez-Fuentes M, et al. Immunologic Human Renal Allograft Injury Associates with an Altered IL-10/TNF-alpha Expression Ratio in Regulatory B Cells. J Am Soc Nephrol 2014; 25: 1575-1585.
42. Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010; 184: 4801-4809.
43. Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, et al. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol 2013; 131: 1674-1682.
44. Miyazaki D, Kuo CH, Tominaga T, Inoue Y, Ono SJ,. Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis. Invest Ophthalmol Vis Sci 2009; 50: 1626-1635.
45. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG,. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 2010; 125: 1114-1124.
46. Mangan NE, Fallon RE, Smith P, van Rooijen N, McKenzie AN, Fallon PG,. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol 2004; 173: 6346-6356.
47. Mangan NE, van Rooijen N, McKenzie AN, Fallon PG,. Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J Immunol 2006; 176: 138-147.
48. van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A, Lievers E, Gloudemans AK, Liu KY, et al. Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS ONE 2012; 7: e30883.
49. Noh J, Lee JH, Noh G, Bang SY, Kim HS, Choi WS, et al. Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br 1) in Cow Milk Allergy. Cell Immunol 2010; 264: 143-149.
50. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199: 1567-1575.
51. van der Vlugt LE, Mlejnek E, Ozir-Fazalalikhan A, Janssen Bonas M, Dijksman TR, Labuda LA, et al. CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy 2014; 44: 517-528.
52. Matsumoto M, Fujii Y, Baba A, Hikida M, Kurosaki T, Baba Y,. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 2011; 34: 703-714.
53. Mann M, Maresz K, Shriver L, Tan Y, Dittel B,. B cell regulation of CD4+ CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 2007; 178: 3447-3456.
54. Mauri C, Gray D, Mushtaq N, Londei M,. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003; 197: 489-501.
55. Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, Kountikov EI, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012; 491: 264-268.
56. Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 2011; 121: 3645-3656.
57. Lee KM, Kim JI, Stott R, Soohoo J, O'Connor MR, Yeh H, et al. Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant 2012; 12: 2072-2078.
58. McIntire JJ, Umetsu SE, Akbari O, Potter M, Kuchroo VK, Barsh GS, et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2001; 2: 1109-1116.
59. Xiao S, Brooks CR, Zhu C, Wu C, Sweere JM, Petecka S, et al. Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci USA 2012; 109: 12105-12110.
60. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF,. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009; 182: 7459-7472.
61. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347: 869-877.
62. Yazdanbakhsh M, Kremsner PG, van Ree R,. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 490-494.
63. Fallon PG, Mangan NE,. Suppression of TH2-type allergic reactions by helminth infection. Nat Rev Immunol 2007; 7: 220-230.
64. Lauener RP, Birchler T, Adamski J, Braun-Fahrländer C, Bufe A, Herz U, et al. Expression of CD14 and Toll-like receptor 2 in farmers' and nonfarmers' children. Lancet 2002; 360: 465-466.
65. Ege MJ, Bieli C, Frei R, van Strien RT, Riedler J, Ublagger E, et al. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J Allergy Clin Immunol 2006; 117: 817-823.
66. von Mutius E, Vercelli D,. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol 2010; 10: 861-868.
67. Kollmann TR, Levy O, Montgomery RR, Goriely S,. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012; 37: 771-783.
68. Belderbos ME, Knol EF, Houben ML, van Bleek GM, Wilbrink B, Kimpen JL, et al. Low neonatal Toll-like receptor 4-mediated interleukin-10 production is associated with subsequent atopic dermatitis. Clin Exp Allergy 2012; 42: 66-75.
69. Lluis A, Depner M, Gaugler B, Saas P, Casaca VI, Raedler D, et al. Increased regulatory T-cell numbers are associated with farm milk exposure and lower atopic sensitization and asthma in childhood. J Allergy Clin Immunol 2014; 133: 551-559.
70. Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, Chichester K, Myers L, Halushka MK, et al. TGFbeta receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med 2013; 5: 195ra194.
71. Natarajan P, Singh A, McNamara JT, Secor ER Jr, Guernsey LA, Thrall RS, et al. Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-beta, and co-localize with CD4+ Foxp3+ T cells. Mucosal Immunol 2012; 5: 691-701.
72. Liu ZQ, Wu Y, Song JP, Liu X, Liu Z, Zheng PY, et al. Tolerogenic CX3CR1+ B cells suppress food allergy-induced intestinal inflammation in mice. Allergy 2013; 68: 1241-1248.
73. Zhang HP, Wu Y, Liu J, Jiang J, Geng XR, Yang G, et al. TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation. Sci Rep 2013; 3: 3345.
74. Montandon R, Korniotis S, Layseca-Espinosa E, Gras C, Megret J, Ezine S, et al. Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci USA 2013; 110: 2199-2208.
75. Lundy SK, Boros DL,. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun 2002; 70: 812-819.
76. Klinker MW, Reed TJ, Fox DA, Lundy SK,. Interleukin-5 supports the expansion of fas ligand-expressing killer B cells that induce antigen-specific apoptosis of CD4(+) T cells and secrete interleukin-10. PLoS ONE 2013; 8: e70131.
77. Hagn M, Belz GT, Kallies A, Sutton VR, Thia KY, Tarlinton DM, et al. Activated mouse B cells lack expression of granzyme B. J Immunol 2012; 188: 3886-3892.
78. Hagn M, Sontheimer K, Dahlke K, Brueggemann S, Kaltenmeier C, Beyer T, et al. Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help. Immunol Cell Biol 2012; 90: 457-467.
79. Pipet A, Botturi K, Pinot D, Vervloet D, Magnan A,. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Respir Med 2009; 103: 800-812.
80. Akdis M, Akdis CA,. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 2014; 133: 621-631.
81. Aalberse RC, Stapel SO, Schuurman J, Rispens T,. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009; 39: 469-477.
82. Canfield SM, Morrison SL,. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J Exp Med 1991; 173: 1483-1491.
83. van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martinez-Martinez P, Vermeulen E, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317: 1554-1557.
84. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C,. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120: 707-713.
85. Piconi S, Trabattoni D, Rainone V, Borgonovo L, Passerini S, Rizzardini G, et al. Immunological effects of sublingual immunotherapy: clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4. J Immunol 2010; 185: 7723-7730.
86. Vickery BP, Lin J, Kulis M, Fu Z, Steele PH, Jones SM, et al. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol 2013; 131: 128-134.
87. Suarez-Fueyo A, Ramos T, Galan A, Jimeno L, Wurtzen PA, Marin A, et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol 2014; 133: 130-138.
88. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M,. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008; 205: 2887-2898.
89. Kaneko Y, Nimmerjahn F, Ravetch JV,. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006; 313: 670-673.
90. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 452-457.
91. Oefner CM, Winkler A, Hess C, Lorenz AK, Holecska V, Huxdorf M, et al. Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J Allergy Clin Immunol 2012; 129: 1647-1655.
92. Gloudemans AK, Lambrecht BN, Smits HH,. Potential of immunoglobulin A to prevent allergic asthma. Clin Dev Immunol 2013; 2013: 542091.
93. Chen KW, Focke-Tejkl M, Blatt K, Kneidinger M, Gieras A, Dall'Antonia F, et al. Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients. Allergy 2012; 67: 609-621.